The novel depot of buprenorphine propionate has a long-acting effect on physical dependence on morphineLIU, Kuo-Sheng; LIN, Ching-Nan; SHIEH, Ja-Ping et al.Drug development research. 2006, Vol 67, Num 5, pp 462-469, issn 0272-4391, 8 p.Article

Serious overdoses involving buprenorphine in HelsinkiBOYD, T; RANDELL, T; LUURILA, H et al.Acta anaesthesiologica scandinavica. 2003, Vol 47, Num 8, pp 1031-1033, issn 0001-5172, 3 p.Article

Taux de pénétration des génériques de la buprénorphine haut dosage: principales tendances de 2006 à 2008 = National and Regional Market Penetration Rates of Generic's High Dosage Buprenorphine: Its Evolution from 2006 to 2008BOCZEK, Christelle; FRAUGER, Elisabeth; MICALLEF, Joëlle et al.Thérapie (Paris). 2012, Vol 67, Num 2, pp 129-136, issn 0040-5957, 8 p.Article

BuprenorphineFOSTER, Bethany; TWYCROSS, Robert; MIHALYO, Mary et al.Journal of pain and symptom management. 2013, Vol 45, Num 5, pp 939-949, issn 0885-3924, 11 p.Article

Novel depots of buprenorphine prodrugs have a long-acting antinociceptive effectLIU, Kuo-Sheng; TZENG, Jann-Inn; CHEN, Yu-Wen et al.Anesthesia and analgesia. 2006, Vol 102, Num 5, pp 1445-1451, issn 0003-2999, 7 p.Article

Buprenorphine use : The international experiencePATRIZIA CARRIERI, Maria; AMASS, Leslie; LUCAS, Gregory M et al.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S197-S215, SUP4Conference Paper

Opioid Syndrome: Failed Opioid Therapy for Chronic Noncancer PainKAMEN, Leonard B; FEEKO, Kristofer J.Physical medicine and rehabilitation clinics in North America. 2014, Vol 25, Num 2, issn 1047-9651, 375-395, ix [22 p.]Article

Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV CareCHAUDHRY, Amina A; BOTSKO, Michael; WEISS, Linda et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 56, issn 1525-4135, S14-S21, SUP1Article

The synthesis of buprenorphine intermediates by regioselective microbial N- and O-demethylation reactions using Cunninghamella echinulata NRRL 1384ABEL, Anthony M; CARNELL, Andrew J; DAVIS, J. Alf et al.Enzyme and microbial technology. 2003, Vol 33, Num 5, pp 743-748, issn 0141-0229, 6 p.Article

Effects of Transdermal Buprenorphine on Patients-reported Outcomes in Cancer Patients: Results From the Cancer Pain Outcome Research (CPOR) Study GroupAPOLONE, Giovanni; CORLI, Oscar; NEGRI, Emanuele et al.The Clinical journal of pain. 2009, Vol 25, Num 8, pp 671-682, issn 0749-8047, 12 p.Article

Reversibility of opioid receptor occupancy of buprenorphine in vivoENGLBERGER, Werner; KÖGEL, Babette; FRIDERICHS, Elmar et al.European journal of pharmacology. 2006, Vol 534, Num 1-3, pp 95-102, issn 0014-2999, 8 p.Article

Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?JENKINSON, Rebecca A; CLARK, Nicolas C; FRY, Craig L et al.Addiction (Abingdon. Print). 2005, Vol 100, Num 2, pp 197-205, issn 0965-2140, 9 p.Article

Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphineZHE DING; RAFFA, Robert B.British journal of pharmacology. 2009, Vol 157, Num 5, pp 831-843, issn 0007-1188, 13 p.Article

Factors associated with complicated buprenorphine inductionsWHITLEY, Susan D; SOHLER, Nancy L; KUNINS, Hillary V et al.Journal of substance abuse treatment. 2010, Vol 39, Num 1, pp 51-57, issn 0740-5472, 7 p.Article

Buprenorphine tapering schedule and illicit opioid useLING, Walter; HILLHOUSE, Maureen; SELZER, Jeffrey et al.Addiction (Abingdon. Print). 2009, Vol 104, Num 2, pp 256-265, issn 0965-2140, 10 p.Article

Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusersDUKE, Angela N; CORREIA, Christopher J; WALSH, Sharon L et al.Psychopharmacologia. 2010, Vol 211, Num 3, pp 303-312, issn 0033-3158, 10 p.Article

Buprénorphine:faut-il sevrer?PORCHER, Marion; POUTRAIN, Jean-Christophe; LAPEYRE-MESTRE, Maryse et al.La Revue du praticien. Médecine générale. 2012, Num 876, pp 166-167, issn 0989-2737, 2 p.Article

Reflexions pratiques sur les médicaments détournés de leur usage = Practical reflections on the misuse of drugsBOULEY, M; VIRIOT, E; BARACHE, D et al.Thérapie (Paris). 2000, Vol 55, Num 2, pp 295-301, issn 0040-5957Article

Politique d'observation des pratiques cliniques liées a l'utilisation de la buprénorphinePARQUET, Philippe-Jean.THS la revue des addictions. 2006, Vol 8, Num 29, pp 1453-1454, issn 1624-0898, 2 p.Article

Local Anesthetic-like Inhibition of Voltage-gated Na⁺ Channels by the Partial μ-opioid Receptor Agonist BuprenorphineLEFFLER, Andreas; FRANK, Georg; KISTNER, Katrin et al.Anesthesiology (Philadelphia). 2012, Vol 116, Num 6, pp 1335-1346, issn 0003-3022, 12 p.Article

Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugsNORDBØ, A; SKURTVEIT, S; BORCHGREVINK, P. C et al.Acta anaesthesiologica scandinavica. 2012, Vol 56, Num 1, pp 88-94, issn 0001-5172, 7 p.Article

Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteersYASSEN, Ashraf; OLOFSEN, Erik; ROMBERG, Raymonda et al.Anesthesiology (Philadelphia). 2006, Vol 104, Num 6, pp 1232-1242, issn 0003-3022, 11 p.Article

Open-label trial of an injection depot formulation of buprenorphine in opioid detoxificationSOBEL, Bai-Fang X; SIGMON, Stacey C; WALSH, Sharon L et al.Drug and alcohol dependence. 2004, Vol 73, Num 1, pp 11-22, issn 0376-8716, 12 p.Article

Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerationsTZSCHENTKE, Thomas M.Psychopharmacologia. 2004, Vol 172, Num 1, pp 58-67, issn 0033-3158, 10 p.Article

Intoxications par opiacés/opioïdes depuis l'avènement de la buprénorphine haut dosage = Opiate/opioid poisonings since the advent of high dosage buprenorphineGUEYE, Papa; PIRNAY, Stéphane; MEGARBANE, Bruno et al.Alcoologie et addictologie. 2004, Vol 26, Num 3, pp 235-242, issn 1620-4522, 8 p.Article